pharma · Chronic Hepatitis D Infection · Chronic Hepatitis Delta Infection
Blue Earth Diagnostics
Blue Earth Diagnostics Ireland Ltd
Blue Earth Diagnostics is a pharma organization headquartered in GB. Primary therapeutic focus areas include Chronic Hepatitis D Infection, Chronic Hepatitis Delta Infection, PSMA-positive non-curative metastatic castrat
Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, GB HQ
2014 Founded
120 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, GB
- Founded
- 2014
- Employees
- 120
- Programs
- 11
- Drugs
- 12
- Patents
- 0
Lutetium (177Lu) rhPSMA-10.1 injection
Phase 2 · small molecule · Metastatic castration-resistant prostate cancer (mCRPC)
Lutetium (177Lu) rhPSMA-10.1 injection for Metastatic castration-resistant prostate cancer (mCRPC) is a Phase 2 program (small_molecule) at Blue Earth Diagnostics Ireland Ltd with 1 ClinicalTrials.gov record(s).
Internal code BET-PSMA-121
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Blue Earth Diagnostics Ireland Ltd
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Metastatic castration-resistant prostate cancer (mCRPC)
- Status
- active
- Trials
- 1